---
share: "true"
BOX:
  - ê°•ì˜ë¡
í•™ê¸°:
  - "08"
ê³¼ëª©:
  - ë‚´ê³¼í•™1
íŒ€í‹°ì¹­: í˜„ë‚´
ì°¨ì‹œ: 1ì£¼ì°¨
ì§„í–‰ë¥ :
  - ì •ë¦¬_ì¤‘ê°„
tags:
  - 08ì¤‘ê°„
---

# Clinical Approach and Laboratory Evaluation of Urinary Disease

## 1. Kidney

- ì‹ ì¥ ì§ˆí™˜ì€ ê°œë‚˜ ê³ ì–‘ì´ì—ì„œ í˜¸ë°œí•˜ëŠ” ì¥ê¸° ì´ìƒ ì§ˆí™˜ìœ¼ë¡œ, í™˜ìì˜ ì‚¬ë§ë¥ ì— ì˜í–¥ì„ ë¼ì¹˜ëŠ” ì£¼ ì›ì¸ì´ë‹¤.
- ì‹ ì¥ ì§ˆí™˜ì˜ ìœ ë³‘ë¥ (prevalence) ë˜í•œ ë†’ì€ í¸. (ê°œì—ì„œ 0.5-7%, ê³ ì–‘ì´ì—ì„œ 1.6-20%)
- ì‹ ì¥ì˜ ê¸°ëŠ¥
	- (1) **ì†Œë³€ì˜ í˜•ì„±**(urine formation)
		- ì‚°ì„±ë„ë¥¼ ì¡°ì ˆí•˜ì—¬ í•­ìƒì„± ìœ ì§€ (maintenance of normal fluid balance)
		- ë…¸íë¬¼ ë°°ì„¤ (removal of metabolic waster products)
	- (2) **í˜ˆì•¡ ìƒì„±**ì— ê´€ì—¬ (production of cell blood cells)
		- [[erythropoietin|erythropoietin]] í•©ì„± ë° ë¶„ë¹„
		- cardiac outputì˜ 25%ê°€ ì‹ ì¥ì— ì˜¨ë‹¤ê³  í•  ë§Œí¼ í˜ˆë¥˜ ì˜ì¡´ì„± ë†’ìŒ
	- (3) **ì „ì‹  í˜ˆì•• ì¡°ì ˆ** (regulation of blood pressure)
		- ë‚®ì€ í˜ˆì•• â†’ Na+ ë°°ì„¤ ì¤‘ë‹¨(retention), renin í™œì„±í™”, angiotensin 2 ë¶„ë¹„(renin-angiotensin-aldosterone activation), ë§ì´ˆ í˜ˆê´€ ìˆ˜ì¶• â†’ í˜ˆì•• ìƒìŠ¹
		- ë†’ì€ í˜ˆì•• â†’ Na+ ê³¼ë‹¤ ë°°ì„¤(excretion), prostaglandin ë¶„ë¹„ ì´‰ì§„, ëª¨ì„¸í˜ˆê´€ í™•ì¥
	- (4) **ë¹„íƒ€ë¯¼D í•©ì„±** â†’ ë¼ˆ í˜•ì„± (skeleton formation)
		- ë¹„íƒ€ë¯¼D â†’ ë¯¸ë„¤ë„ ëŒ€ì‚¬ ì˜í–¥ ì¸ì(parathyroid hormone, clacitonin ë“±) ì¡°ì ˆí•˜ëŠ” ì—­í• 
		- ë§Œì„± ì‹ ë¶€ì „ í™˜ìì˜ ê²½ìš°, ë¹„íƒ€ë¯¼D/ì¹¼ìŠ˜/ì¸ ë“± í˜¸ë¥´ëª¬ ë¶„ë¹„ì— ì˜í–¥ì„ ë°›ê¸° ë•Œë¬¸ì— ë¼ˆ ëŒ€ì‚¬ì— ì¥ì• ë¥¼ ì¤„ ìˆ˜ ìˆìŒ

### Urine formation

![[Pasted image 20240917191025.png|400]]

- ì‹ ì¥ì˜ ê¸°ë³¸ ë‹¨ìœ„ : **Nephron**
	- ë„¤í”„ë¡  = ì‹ ì†Œì²´(renal corpuscle) + ì‹ ì„¸ë‡¨ê´€(renal tubules)
		- ì‹ ì†Œì²´ = ì‚¬êµ¬ì²´, ì‚¬êµ¬ì²´ë‚­ í¬í•¨
- ê°œëŠ” **40-50ë§Œ ê°œ**, ê³ ì–‘ì´ëŠ” **20ë§Œ ê°œ** ì •ë„ì˜ ë„¤í”„ë¡ ìœ¼ë¡œ ì‹ ì¥ êµ¬ì„±

>[!note] Podocyte
>- podocyteê°€ í˜ˆê´€ì— process(ëŒê¸°)ë¥¼ ë»—ì–´ ë¶€ì°©í•œë‹¤.
>- ì¤‘ê°„ì¤‘ê°„ poreê°€ ìƒê¸°ëŠ”ë°, ì´ poreì˜ í¬ê¸°ê°€ í˜ˆì•¡ì—ì„œ ì†Œë³€ìœ¼ë¡œ ì—¬ê³¼ë˜ëŠ” í¬ê¸°ë¥¼ ê²°ì •í•œë‹¤.
>- ì¼ë°˜ì ìœ¼ë¡œ 6ë§Œ ë‹¬í†¤ì˜ í¬ê¸° â†’ ëŒ€ë¶€ë¶„ì˜ ì„¸í¬ëŠ” ì´ë³´ë‹¤ ì»¤ì„œ ì •ìƒì ìœ¼ë¡œëŠ” ì—¬ê³¼ë˜ì§€ ì•ŠëŠ”ë‹¤.
>	- ì‚¬êµ¬ì²´ì—¼ì´ë‚˜ ì†ìƒìœ¼ë¡œ podocyteê°€ ì†ì‹¤ë˜ì–´ êµ¬ë©ì´ ì»¤ì§€ë©´ ë¬´ë¶„ë³„í•œ ì—¬ê³¼ê°€ ë°œìƒ.
>- ì²˜ìŒ ë¹ ì ¸ë‚˜ê°€ëŠ” ì•¡ì²´ = ì—¬ê³¼ì•¡ = ë¬¼, ì‘ì€ ìš©ì§ˆ(urea, creatin ë“±)ì„ í¬í•¨
>![[Pasted image 20240917192256.png|300]]

- ì •ìƒì ì¸ urine ìƒì„±ëŸ‰ (dog&cats) : **20-45mL/kg/day**
![[Pasted image 20240917192556.png|550]]

## 2. Clinical Approach

### (1) History taking (ë¬¸ì§„)

- **presenting complaint**
	-  onset : ê¸‰ì„±? ì ì§„ì ?
	- progresssion : ì§„í–‰? ìœ ì§€? ì•…í™”?
	- ì´ì „ ì¹˜ë£Œì— ëŒ€í•œ ë°˜ì‘
- **signalment** : ë™ë¬¼ì— ëŒ€í•œ ìì„¸í•œ ì„¤ëª… (í’ˆì¢…ì˜ ë‚˜ì´, ì„±ë³„, ë…íŠ¹í•œ íŠ¹ì§• ë“±)
- **environment** : ì‹¤ë‚´? ì‹¤ì™¸?
- **geographic origin & travel history** : ì–´ë””ì„œ ì™”ê³ , ì–´ë””ë¥¼ ë‹¤ë…”ëŠ”ì§€
- **exposure to other animals** : ë‹¤ë¥¸ í™˜ìì™€ ì ‘ì´‰ ì—¬ë¶€ â†’ ê°ì—¼ì„± ì§ˆí™˜ì¸ì§€ í™•ì¸
- **vaccination status** : ì™¸ë¶€ ê¸°ìƒì¶©ì— ëŒ€í•œ êµ¬ì¶© ë“±
- **diet** : ì‹ì´
- **previous trauma, illness, surgery** : ì´ì „ ë³‘ë ¥
- **exposure to potential nephrotoxins** : ì‹ ì¥ ë…ì„±ì„ ìœ ë°œí•˜ëŠ” ë¬¼ì§ˆë“¤
	- Ethylene glycol in antifreeze : ë¶€ë™ì•¡ ë…¸ì¶œ?
	- chicken jerky treats (ê°œ)
	- easter lilies (ê³ ì–‘ì´) : ë°±í•© ë…¸ì¶œ?
	- aminoglycosides
	- NSAIDs : í•­ìƒì œ ë³µìš© ê²½í—˜
- **ìŠ¤íŠ¸ë ˆìŠ¤ì„± events** : ê³ ì–‘ì´ëŠ” íŠ¹íˆ ìŠ¤íŠ¸ë ˆìŠ¤ì— ì·¨ì•½

### (2) Clinical signs (ì„ìƒ ì¦ìƒ)

ì„ìƒ ì¦ìƒë§Œìœ¼ë¡œ ê°ë³„ ì§„ë‹¨ì€ ì–´ë ¤ìš´ í¸.

- **Anuria** (ë¬´ë‡¨) : ì˜¤ì¤Œì´ ì œëŒ€ë¡œ ìƒì„±ë˜ì§€ ì•Šê±°ë‚˜, ë°°ì¶œë˜ì§€ ì•ŠìŒ
	- ì£¼ë¡œ ìš”ë¡œ íìƒ‰ìœ¼ë¡œ ì¸í•´ ë°œìƒ, AKI(ê¸‰ì„± ì‹ ë¶€ì „, Acute Kidney Injury) ì˜ì‹¬
- **Oliguria** (í•ë‡¨) : urine output ê°ì†Œ
	- ë¶€ë¶„ ìš”ë¡œ íìƒ‰, ì‹ ë¶€ì „ ì˜ì‹¬, ì „ì‹  íƒˆìˆ˜ ì§ˆí™˜, UTI (ìš”ë¡œê°ì—¼ì¦)
- **Polyuria** (ë‹¤ë‡¨) : ë¹„ì •ìƒì ìœ¼ë¡œ ë§ì€ urine ìƒì„± ë˜ëŠ” ë°°ì¶œ / ì£¼ë¡œ ìƒë¶€ ë¹„ë‡¨ê³„ ë¬¸ì œ
- **Dysuria** (ë°°ë‡¨í†µ) : ë°°ë‡¨ ê³¤ë€, í†µì¦
- **Stranguia** (í†µì¦ë°°ë‡¨) : ëŠë¦¬ê³  ê³ í†µìŠ¤ëŸ¬ìš´ ë°°ë‡¨
	- ìš”ë„, ë°©ê´‘ì˜ ê·¼ìœ¡ ê²½ë ¨(spasms) ë“±ì— ì˜í•¨
- **Pollakiuria** (ë¹ˆë‡¨) : ì†ŒëŸ‰ì”© ìì£¼ ë°°ë‡¨ / ì£¼ë¡œ í•˜ë¶€ ìš”ë¡œê³„ ë¬¸ì œ
- **Urinary incontinence** (ìš”ì‹¤ê¸ˆ) : ë¹„ìë°œì  ë°°ë‡¨ (í†µì œ ë¶ˆê°€)
- **Nocturia** (ì•¼ë‡¨) : ë°¤ì— ë°°ë‡¨í•˜ê³  ì‹¶ì–´ì§, ë…¸ë ¹ ë™ë¬¼ì—ì„œ ì£¼ë¡œ ë°œìƒ
	- ë‹¤ë‡¨ë‚˜ ìš”ì‹¤ê¸ˆì˜ ì´ˆê¸° ì¦ìƒì¼ ìˆ˜ ìˆìŒ
- **Hematuria** (í˜ˆë‡¨)
- **Pyuria** (ë†ë‡¨)
- **Malodorous** urine (ì•…ì·¨ ë‚˜ëŠ” ì†Œë³€)

ë¹„íŠ¹ì´ì ì¸ ì‹ ì¥ ì§ˆí™˜ ì¦ìƒìœ¼ë¡œ **lethargy**(ê¸°ë ¥ ì €í•˜), **anorexia**(ì‹ìš• ë¶€ì§„), **weight loss**(ì²´ì¤‘ ê°ì†Œ) ë“±ì´ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŒ.

>[!check] ì†Œë³€ëŸ‰ ê°ë³„ ê¸°ì¤€
>- ì •ìƒ ì†Œë³€ëŸ‰ : 1-2ml/kg/hour
>- ë¬´ë‡¨, í•ë‡¨ : ==6ì‹œê°„ ì´ìƒ 1-2ml/kg/h== ì´í•˜ OR ==12ì‹œê°„ ì´ìƒ ë°°ë‡¨ ì—†ìŒ==
>- ë‹¤ë‡¨ : <u>50ml/kg/day</u>
>- ìŒìˆ˜ëŸ‰ ê¸°ì¤€
>	- ì •ìƒ ê°œ : 60-90ml/kg/day
>	- ì •ìƒ ê³ ì–‘ì´ : 45ml/kg/day
>	- ë‹¤ìŒ(**Polydipsia**) : <u>100ml/kg/day ì´ìƒ</u>

### (3) Physical examination (ì‹ ì²´ ê²€ì‚¬)

Complete physical examination

![[Pasted image 20240917201130.png|550]]

| í•­ëª©                             | ë‚´ìš©                                                       |
| ------------------------------ | -------------------------------------------------------- |
| **Body condition, BW(ì²´ì¤‘)**         |                                                          |
| **TPR, ì²­ì§„, BP(í˜ˆì••)**                | TPR=Temperature, Pulse, Respiratory rate (ì²´ì˜¨ ë§¥ë°• í˜¸í¡)      |
| **íƒˆìˆ˜ ìƒíƒœ, ë³µìˆ˜/í”¼í•˜ë¶€ì¢… ì—¬ë¶€**              |                                                          |
| **êµ¬ê°• ê²€ì‚¬**                          | ê¶¤ì–‘, tougue tip necrosis, ì ë§‰ì˜ ì°½ë°±í•¨                         |
| **ì•ˆì € ê²€ì‚¬ (fundic)**                 | ë§ë§‰ ë¶€ì¢…, ë§ë§‰ë°•ë¦¬(ë¶„ë¦¬), ì¶œí˜ˆ, í˜ˆê´€ ë’¤í‹€ë¦¼                              |
| **ì‹ ì¥ ì´‰ì§„**                          | í¬ê¸°, ëª¨ì–‘, ë°€ë„, í†µì¦, ìœ„ì¹˜                                       |
| **ë°©ê´‘ ì´‰ì§„**                          | íŒ½ì°½ ì •ë„, í†µì¦, ë²½ ë‘ê»˜,<br>ì¢…ê´´ ì—¬ë¶€- ì¢…ì–‘(tumor), ê²°ì„(calculi), clots |
| **ì§ì¥ ê²€ì‚¬ (rectal)**                 | ì „ë¦½ìƒ˜(prostate gland), ìš”ë„(pelvic urethra) í‰ê°€               |
| **ìƒì‹ê¸° ê²€ì‚¬ (genital)**               |                                                          |
| **Fibrous osteodystrophy (ê³¨í˜•ì„±ì´ìƒ)** | (íŠ¹íˆ ì–´ë¦° ë™ë¬¼ì—ì„œ)                                             |

intraluminal = within a lumen (ë‚´ê°•)
intramural = ë²½ë‚´..ì¸ë“¯?

### (4) Diagnostic tests (ì‹ ì¥ ê¸°ëŠ¥ ê²€ì‚¬) 

ì—¬ê¸°ë¶€í„°ê°€ ë³¸ë¡ ì…ë‹ˆë‹¤.. ë‚˜ë¨¸ì§€ 2/3ê°€ ì—¬ê¸° 

#### ğŸŸ  ì‚¬êµ¬ì²´ ê¸°ëŠ¥ í‰ê°€ (Assessment of Glomerular function)

##### ğŸ”º Glomerular filtration rate (GFR, ì‚¬êµ¬ì²´ ì—¬ê³¼ìœ¨)

![[GFR (Glomerular filtration rate)|GFR (Glomerular filtration rate)]]

##### ğŸ”º Blood urea nitrogen (BUN)

![[Blood urea nitrogen (BUN)|Blood urea nitrogen (BUN)]]

##### ğŸ”º Serum creatinine (SCr)
![[Serum creatinine (SCr)|Serum creatinine (SCr)]]

![[BUNê³¼ SCrì˜ relationship|BUNê³¼ SCrì˜ relationship]]

##### ğŸ”º Symmetric dimethylarginine (SDMA)

##### ğŸ”º Evaluation of proteinuria (ë‹¨ë°±ë‡¨)

#### ì„¸ë‡¨ê´€ ê¸°ëŠ¥ í‰ê°€ (Assessment of Tubular function)

#### Other tests